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PHF20 is a core component of the lysine acetyltrans-
ferase complex MOF (male absent on the first)-NSL
(non-specific lethal) that generates the major epige-
netic mark H4K16ac and is necessary for transcrip-
tional regulation and DNA repair. The role of PHF20
in the complex remains elusive. Here, we report on
functional coupling between methylation readers in
PHF20. We show that the plant homeodomain
(PHD) finger of PHF20 recognizes dimethylated
lysine 4 of histone H3 (H3K4me2) and represents an
example of a native reader that selects for this modi-
fication. Biochemical and structural analyses help to
explain this selectivity and the preference of Tudor2,
another reader in PHF20, for dimethylated p53. Bind-
ing of the PHD finger to H3K4me2 is required for
histone acetylation, accumulation of PHF20 at target
genes, and transcriptional activation. Together, our
findings establish a unique PHF20-mediated link
between MOF histone acetyltransferase (HAT), p53,
and H3K4me2, and suggest a model for rapid
spreading of H4K16ac-enriched open chromatin.
INTRODUCTION
PHF20 is a component of theMOF (male absent on the first)-NSL
(non-specific lethal) lysine acetyltransferase complex respon-
sible for acetylation of histone H4 and non-histone proteins
and is implicated in transcriptional regulation and Ataxia telangi-
ectasia mutated (ATM)-dependent DNA damage response
(Avvakumov and Co^te´, 2007; Cai et al., 2010; Li et al., 2009;
Rea et al., 2007). The MOF-NSL complex shares the WD repeat
domain 5 (WDR5) subunit with the H3K4-specificmethyltransfer-
ase complex, MLL1, and stably associates with the MLL1 com-
plex (Cai et al., 2010; Dou et al., 2005; Zhao et al., 2013b). The1158 Cell Reports 17, 1158–1170, October 18, 2016 ª 2016 The Auth
This is an open access article under the CC BY-NC-ND license (http://joint recruitment and coordinated activities of both MOF and
MLL1 complexes are required for optimal transcriptional activa-
tion of a set of genes, and a synergistic distribution of H3K4me
and H4K16ac marks at promoters of these genes is evident
(Dou et al., 2005; Zhao et al., 2013b). Genomic and biochemical
studies reveal that MOF-NSL stimulates MLL1 activity,
enhancing dimethylation of H3K4 in an acetylation-dependent
manner, and depletion of MOF or the NSL complex results in a
reduction of H4K16 acetylation and H3K4 methylation (Zhao
et al., 2013b).
TheMOF-NSL complex is also capable of acetylating non-his-
tone proteins, such as the transcription factor p53. Triggered by
DNA damage, K120 acetylation in the DNA-binding domain of
p53 stimulates expression of pro-apoptotic genes, promoting
cell death (Li et al., 2009; Sykes et al., 2006). Additionally, p53 ac-
tivity can be regulated by non-catalytic subunits of theMOF-NSL
complex, OGT1 and PHF20. OGT1-catalyzed O-GlcNAcylation
at S149 stabilizes p53 through impeding T155 phosphorylation
and ubiquitin-dependent proteolysis of p53 (Yang et al., 2006).
PHF20 directly binds to p53 dimethylated at K370 or K382
(p53K370me2 and p53K382me2) through its second Tudor
(Tudor2) domain (Cui et al., 2012). Tudor2 forms a dimer capable
of associating with both p53 dimethyllysine marks simulta-
neously, thus greatly enhancing binding of PHF20 to p53 (Cui
et al., 2012). Interaction with PHF20 leads to the stabilization
and activation of p53, because it blocks p53 ubiquitination and
upregulates p53 in response to DNA damage (Cui et al., 2012).
Recent in vivo and in vitro studies demonstrate that PHF20 tran-
scriptionally regulates p53 in an Akt-dependent manner (Park
et al., 2012) and promotes nuclear factor kB (NF-kB) transcrip-
tional activity (Zhang et al., 2013). Loss of PHF20 results in a
decreased expression of genes with elevated H4K16ac levels
at their promoters, further supporting the notion that PHF20
acts as a transcriptional regulator (Badeaux et al., 2012).
Originally identified as an antigen in glioblastoma patients,
PHF20 is highly expressed in a number of cancers and is impli-
cated in the development and progression of glioma, adenocar-
cinomas, and lung cancer (Bankovic et al., 2010; Fischer et al.,or(s).
creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. PHF20 Is Amplified in LungCancer
Cells and Is Required for Cancer Cell
Growth and Survival
(A and B) PHF20 is amplified in lung adenocarci-
noma cell lines. qRT-PCR (A) and western blot
analysis (B) of PHF20 gene expression and protein
levels, respectively, in the indicated lung adeno-
carcinoma cell lines and control immortalized
normal cells. GAPDH was used as internal control
in (A), and actin was used as a loading control in
(B). Error bars represent SEM of three replicates.
(C) Heatmap and IPA of gene expression profiles in
the control (shNT) and PHF20 KD (shPHF20)
H1792 cells. The green and red colors indicate
down- and upregulation, respectively. The right
panel shows the IPA of the down- and upregulated
genes in PHF20 KD cells. The top five hits in each
category are listed. The full lists of up- and
downregulated genes are provided in Table S1.
(D) Cell proliferation assays of the control and
PHF20 KD H1792 cells. Live cells were counted
over a 6-day time course. Error bars represent
SEM of six replicates.
(E and F) Colony formation assays of the control
and PHF20 KD H1792 cells. Representative crys-
tal-violet-stained cells are shown in (E), and
quantification is shown in (F).
Error bars represent SEM of six replicates.
**p < 0.01. See also Figure S1 and Table S1.2001; Heisel et al., 2008; Taniwaki et al., 2006). Overexpression
of PHF20 is proposed to drive constitutive NF-kB activation in
some tumors (Zhang et al., 2013). PHF20 knockout mice die
shortly after birth and display a variety of phenotypes within
the skeletal and hematopoietic systems (Badeaux et al., 2012).
PHF20 deficiency halts conversion of somatic cells into induced
pluripotent stem cells (iPSCs), revealing a requirement of this
factor for cell reprogramming (Zhao et al., 2013a). Despite the vi-W
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genesis, the molecular mechanism by
which PHF20 contributes to transcription
and p53 regulation and exerts carcino-
genic activity remains unclear. In this
work, we report on a unique function of
PHF20 that couples MOF histone
acetyltransferase (HAT) activity with
dimethylated lysine 4 of histone H3
(H3K4me2)–enriched chromatin and p53.
RESULTS AND DISCUSSION
PHF20 Is Required for Cancer Cell
Growth and Survival
To establish the biological function of
PHF20, we first analyzed the TCGA data-
base and assessed PHF20 gene alter-
ations in human cancers. PHF20 is ampli-
fied in a variety of human malignancies,
including colorectal, uterine, cervical,
bladder, and lung cancers (Figure S1A).e then carried out qRT-PCR and immunoblotting analyses to
termine the PHF20 gene expression and protein levels across
umber of lung adenocarcinoma cell lines. Compared with the
rmal lung fibroblast cells (WI-38 and IMR90), PHF20 is overex-
essed in all lung cancer cell lines that we examined, especially
protein levels (Figures 1A and 1B). To identify the genes regu-
ed by PHF20 genome-wide, we knocked down PHF20 gene
pression in H1792 lung adenocarcinoma cells by shortrts 17, 1158–1170, October 18, 2016 1159
Figure 2. The PHF20 PHD Finger Binds to H3K4me2
(A) Schematic representation of PHF20.
(B) Western blot analysis of histone peptide pull-downs with GST-PHF20 PHD and the indicated biotinylated peptides.
(C) Histone peptide array probed with GST-PHF20 PHD.
(D) Superimposed 1H,15N HSQC spectra of the PHF20 PHD finger collected upon titration with the indicated peptides. Spectra are color coded according to the
protein:peptide molar ratio shown on the left.
(E) Binding affinities of WT PHF20 PHD for the indicated histone peptides measured by tryptophan fluorescence.
(F) Representative binding curves used to determine the KD values.hairpins (shRNAs) (Figures S1B and S1C) and performed RNA
sequencing (RNA-seq) analysis. PHF20 was reported as a tran-
scriptional coactivator; however, we found similar numbers of
genes were down- (942 genes) and upregulated (895 genes) in
PHF20 KD cells compared with the control cells (Figure 1C). In-
genuity Pathway Analysis (IPA) revealed that the most affected
genes are implicated in vital biological processes, including
cell cycle and DNA replication, recombination and repair, cellular
movement, and cell proliferation and death. Notably, both down-
and upregulated genes are enriched for cancer, organismal
injury, and connective tissue diseases (Figure 1C). Furthermore,
cell proliferation assays showed that depletion of PHF20 mark-
edly reduced the cell growth and colony formation of H1792 cells1160 Cell Reports 17, 1158–1170, October 18, 2016(Figures 1D–1F). Together, these data suggest that PHF20 has
an oncogenic role in lung adenocarcinoma, promoting cancer
cell growth and survival.
PHF20 Recognizes Histone H3K4me2 via Its PHD Finger
PHF20 has a modular architecture consisting of tandem Tudor
domains (Tudor1 and Tudor2), an AT-hook, a C2H2-type zinc
finger, and a plant homeodomain (PHD) finger (Figure 2A).
Biochemical and structural studies have shown that Tudor2
associates with dimethyllysine substrates (Adams-Cioaba
et al., 2012; Cui et al., 2012; Kim et al., 2006), particularly
with p53K370me2 and p53K382me2 (Cui et al., 2012); however,
biological activities of other domains, including the PHD finger,
Figure 3. Structural Mechanism for the
Recognition of H3K4me2 by PHF20 PHD
(A) The PHD finger is depicted in the ribbon
diagram, and the H3K4me2 peptide is shown in a
stick model. The histone peptide residues and the
residues of the PHF20 PHD finger involved in the
interaction are labeled.
(B) The electrostatic surface potential of the PHF20
PHD finger is shown using blue and red colors for
positive and negative charges, respectively.
(C) An overlay of the NMR structure of the PHF20
PHD-H3K4me2 complex (wheat-green) with the
crystal structure of the apo-state of PHF20 PHD
(gray).
(D) Superimposed H3K4me2 (green)-binding site
of PHF20 PHD (wheat) and H3K4me3 (light blue)-
binding site of ING2 PHD (light blue) (PDB: 2G6Q)
are shown.
See also Figure S2 and Tables S2 and S3.remain unknown. Because a set of PHD finger-containing
proteins was found to bind histone sequences (Li et al., 2006;
Musselman and Kutateladze, 2011; Pen˜a et al., 2006; Shi
et al., 2006; Wysocka et al., 2006), we tested the PHF20 PHD
finger in pull-down assays, histone peptide microarrays, and
nuclear magnetic resonance (NMR). In pull-down assays, gluta-
thione S-transferase (GST) fusion PHD finger was incubated
with biotinylated unmodified histone H3 and H4 peptides or
histone peptides containing single methylation marks. The
histone-bound PHD finger was captured using streptavidin
Sepharose beads and detected by western blot analysis (Fig-
ure 2B). Unexpectedly, we found that the PHF20 PHD finger
binds to H3K4me2 peptide but does not recognize either
H3K4me3 or unmodified H3 that were previously reported as
ligands for PHD fingers. This specificity of the PHF20 PHD
finger toward H3K4me2 was confirmed using an extended pep-
tide microarray (Figure 2C).
To compare binding of the PHF20 PHD finger to the methyl-
ated H3K4 species in more detail, we carried out 1H,15N hetero-
nuclear single quantum coherence (HSQC) titration experiments.
Gradual addition of the H3K4me2 peptide to the 15N-labeled
PHD finger caused large chemical shift perturbations (CSPs) in
the protein, indicating direct binding (Figure 2D). However, inter-
action with H3K4me3 was considerably weaker judging by smallex
of
sp
M
To
H3
th
of
ur
fo
an
ne
H3
br
is
of
ar
gr
wh
ta
E6
caCell RepoCSPs observed upon titration with this
peptide. Quantitative measurements
of binding affinities using fluorescence
spectroscopy further corroborated these
results. The dissociation constant (KD)
for the interaction of the PHF20 PHD
finger with H3K4me2 was found to be
3.6 mM; however, interaction with
H3K4me3, H3K4me1, and H3K4me0
was 6-, 14-, and 20-fold, re-
spectively, weaker (Figures 2E and 2F).
Collectively, our data derived from
four orthogonal biochemical approaches
demonstrate that the PHF20 PHD fingerhibits high selectivity for H3K4me2, representing an example
the native PHD finger capable of reading the dimethylated
ecies.
olecular Basis for the Recognition of H3K4me2
determine the mechanism underlying recognition of
K4me2, we obtained a 1.25-A˚ resolution crystal structure of
e PHF20 PHD finger in the apo-state and the solution structure
the PHD finger in complex with the H3K4me2 peptide (Fig-
e 3; Tables S2 and S3). The NMR ensemble shows a canonical
ld of the PHD finger, consisting of a short double-stranded
tiparallel b sheet, two a-helical turns, and several loops con-
cting two zinc-binding clusters (Figure 3A). The histone
K4me2 peptide is bound in an extended conformation in a
anched negatively charged channel (Figure 3B). The peptide
aligned with b1 of the PHD finger, allowing for the formation
a three-stranded antiparallel b sheet (Figure 3A).
The first six residues of the H3K4me2 peptide, from A1 to T6,
e in direct contact with the PHF20 PHD finger. The methyl
oup of A1 lies in a deep cavity lined with Y692 of the protein,
ereas the amino terminus of A1 is located within a short dis-
nce to the backbone carbonyl oxygen atoms of P689 and
90. The guanidino group of Arg2 is in close proximity to the
rboxyl group of E651. An overlay of the structures of therts 17, 1158–1170, October 18, 2016 1161
PHF20 PHD finger in complex with the H3K4me2 peptide and in
the apo-state reveals that the binding is accompanied by a large
conformational change in the protein N-terminal loop where
E651 resides (Figure 3C). Upon complex formation, E651 swings
toward the core of the PHD finger, most likely forming electro-
static and/or hydrogen bonding contacts with the positively
charged R2 of the H3K4me2 peptide and thereby stabilizing
the complex.
The fully extended side chain of K4me2 occupies an elongated
groove, framed by V653, E662, M666, and W675. The side
chains of E662 and W675, which are oriented perpendicularly
to the protein surface, create the walls of the groove, whereas
V653 and M666 line the bottom. To test the idea that the speci-
ficity of the PHF20 PHD finger for H3K4me2 over H3K4me3 is
due to a smaller size of the methyllysine binding site, we super-
imposed the K4me2-binding groove of PHF20 with the K4me3-
binding pocket of the inhibitor of growth, member 2 (ING2)
PHD finger (Pen˜a et al., 2006) and computed solvent-accessible
surface areas (Figure 3D). We found that the K4me2-binding
groove in PHF20 is slightly larger (273 A˚) compared with the
K4me3-binding pocket of ING2 (200 A˚). These data imply
that the size of the binding pocket is not a factor responsible
for the preference of PHF20 for the dimethyllysine mark.
The Presence of a Glutamate, but Not an Aspartate,
Defines the Specificity for H3K4me2
The current predominant view that helps explain specificity of
some methyllysine-recognizing readers, such as Tudor and
MBT domains, for mono- or dimethylated lysine sequences is
the presence of a negatively charged aspartate or glutamate res-
idue in the methyllysine binding pocket (Li et al., 2007; Mussel-
man et al., 2012; Taverna et al., 2007). However, this view is
not pertinent to PHD fingers because the PHD fingers of MLL5,
TAF3, and Pygo have an aspartate residue (D128, D877, and
D352, respectively) in the methyllysine-binding cage (Figures
4A and 4B), yet MLL5 and TAF3 prefer H3K4me3 over
H3K4me2 by 5- to 10-fold (Ali et al., 2013; van Ingen et al.,
2008; Vermeulen et al., 2007), and Pygo binds both marks with
the same affinity of 2.4–2.5 mM (Fiedler et al., 2008). Because
the PHF20 PHD finger contains the glutamate residue (E662)
instead, we tested whether the longer glutamic side chain ac-
counts for the specificity toward H3K4me2. We generated the
E662D mutant of the PHD finger and examined its binding to
H3K4me2 and H3K4me3 peptides by NMR and tryptophan fluo-
rescence (Figures 4C and 4D). We found that the E662D mutant
of PHF20-PHD interacts with both peptides equally well, exhib-
iting 3.6 mM affinity for H3K4me2 and 3.7 mM affinity for
H3K4me3. These results suggest that the shorter aspartic side
chain in PHF20-PHD E662D does not discriminate between the
tri- and dimethylation states of H3K4, and a longer glutamic
side chain is indeed necessary to select for H3K4me2.
Although we cannot validate hydrogen bond formation in
NMR-derived structures, a short distance between the dimethy-
lammonium group of H3K4 and the carboxylic group of E662
suggests that these groups interact through hydrogen bonding
and ionic contacts. Unlike the trimethylammonium group of
H3K4 in the MLL5 and TAF3 complexes that is located roughly
at equal distance between the aromatic tryptophan residue1162 Cell Reports 17, 1158–1170, October 18, 2016and the aspartic acid (4.7 and 4.0 A˚, respectively, in the
MLL5 complex) (Figure 4B), the position of the dimethylammo-
nium group of H3K4 in the PHF20 complex is shifted toward
E662 (Ali et al., 2013; Lemak et al., 2013; van Ingen et al., 2008).
A similar shift toward the glutamate residue is observed in the
crystal structure of the H3K4me2-bound Y17E mutant of the
PHD finger of bromodomain PHD finger transcription factor
(BPTF) (Li et al., 2007). Thismutant prefers H3K4me2 as opposed
to wild-type (WT) BPTF that selects for H3K4me3 (Li et al., 2007)
and, in support of the binding mode of PHF20, the distances be-
tween K4me2 and W32 and E17 in the Y17E BPTF complex are
4.5 and 2.7 A˚, respectively (Figure 4B). These structural and
biochemical analyses demonstrate that the glutamate residue
present in the K4me2-binding pocket is the major determinant
of the low-methylation state specificity of the PHF20 PHD finger.
Mutations in the PHD Finger Decrease Binding to
H3K4me2
A number of cancer-associated mutations and deletions have
been identified in PHF20, several of which occur in the PHD
finger (Catalogue of Somatic Mutations in Cancer [COSMIC];
Figures 4F and 4G). To determine whether the cancer-relevant
mutations affect binding of the PHD finger to H3K4me2, we pro-
duced R654H, F665V, M666I, and P689L mutants of PHF20
found in stomach, breast, kidney, and lung cancers, and we
tested the corresponding 15N-labeled proteins by NMR (Fig-
ure 4H). We found that binding of R654H, F665V, and P689L to
H3K4me2, compared with WT, was decreased 8-, 9-, and
17-fold, respectively, whereas M666I was unstructured. Map-
ping the cancer-relevant mutations on the structure of the PHD-
H3K4me2 complex revealed that some of the mutated residues
can be essential for proper folding of the domain (such as the hy-
drophobic core residue M666 or a zinc-coordinating residue
C680), or they make contacts with the histone peptide (such as
F665 and P689). Overall, these data demonstrate that some
cancer-relevant mutants have compromised histone-binding
activity and suggest a relationship between this function of
PHF20 and certain cancers.
Substitution of residues in the aromatic dimethyllysine-binding
pocket of the PHF20 PHD finger, including W675 to an alanine
and F665 to a lysine, led to protein misfolding, pointing to the
importance of these aromatic residues for structural stability of
the PHD finger (Figure 4C). Mutation of E662 to a lysine resulted
in a folded, soluble, and stable protein, but completely abro-
gated interaction with both H3K4me2 and H3K4me3, allowing
us to utilize this point mutation in characterizing the functional
significance of the PHD-H3K4me2 interaction in full-length
PHF20 in vivo (Figures 4C and 4E).
Binding of the PHF20 PHD Finger to H3K4me2 Is
Required for MOF-Dependent H4K16 Acetylation and
Gene Regulation
Because PHF20 has been implicated in transcription (Badeaux
et al., 2012; Park et al., 2012; Zhang et al., 2013), we explored
whether the histone-binding activity of the PHD finger is neces-
sary for PHF20/MOF-dependent gene expression. We first
randomly selected 16 downregulated genes in PHF20 KD cells
(see Figure 1C) and performed qPCR analysis to validate the
(legend on next page)
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RNA-seq results. All the genes tested showed considerable
reductions of gene expression upon PHF20 KD by two indepen-
dent shRNAs (Figure 5A). Concomitantly, chromatin immunopre-
cipitation (ChIP) analysis revealed a substantial drop in H4K16ac
levels in promoters of these genes, whereas the total H3 levels
remained unchanged (Figures 5B and S3A). Notably, all the
genes tested have strong H3K4me2 levels on their promoters
(Figure S3B). These findings suggest that PHF20 regulates
gene expression likely through MOF-mediated H4K16ac. To
characterize the role of the PHD finger in this regulation, we de-
signed a reconstitution system in which shRNA-resistant WT
PHF20 or E662K mutant, impaired in binding to H3K4me2, was
reintroduced into the shPHF20 cells. As shown in Figure 5C,
KD of PHF20 led to reduced H4K16ac levels; importantly, WT
PHF20, but not the E662K mutant, rescued the global reduction
of H4K16ac levels. This was further substantiated by measuring
H4K16ac levels in the promoters of PHF20 target genes, such as
CCNA1 andHMGB2. PHF20 KD resulted in decreased H4K16ac
levels, which were fully restored by WT PHF20, but were not
restored by the E662K mutant (Figures 5D and S3C). Subse-
quently, WT PHF20 rescued the defects in target gene expres-
sion, cell proliferation, and colony formation of the PHF20 KD
H1792 cells, whereas the PHD finger mutant E662K, which is
incapable of binding to H3K4me2, failed to do so (Figures 5E–
5H and S3D). Collectively, these results suggest that the
H3K4me2-binding function of the PHD finger is essential for
PHF20-dependent histone acetylation, target gene activation,
and cancer cell growth and survival.
Functional Link between Tudor2 and PHD of PHF20
Along with the PHD finger, PHF20 contains another methyllysine
reader, the tandem Tudor domains, in which Tudor2 recognizes
dimethyllysine substrates, such as p53K370me2 and
p53K382me2 (Adams-Cioaba et al., 2012; Cui et al., 2012; Kim
et al., 2006). To determine whether Tudor2 competes with the
PHD finger for the same posttranslational modification (PTM),
we generated 15N-labeled Tudor2 and examined its interactions
with H3K4me2 and p53K382me2 by 1H,15N HSQC (Figure 6).
Substantial CSPs in PHF20 Tudor2 were observed upon addition
of the p53K382me2 peptide, and in agreement with previous re-
ports (Cui et al., 2012), KD for this interaction was found to be
100 mM (Figures 6A and 6C). In contrast, H3K4me2 peptide
induced small CSPs in Tudor2 and was bound much weaker,
with affinity of 1 mM. To test whether the PHD finger can
compete with Tudor2 for binding to dimethylated p53, we next
titrated the p52K382me2 peptide into the 15N-labeled PHD fingerFigure 4. Molecular Basis for the Selectivity toward Dimethyllysine
(A) Alignment of the PHD finger sequences: absolutely, moderately, and weakly c
H3K4me3-binding site residues of MLL5 and TAF3, as well as the H3K4me2-bin
(B) A close view of the Kme-binding sites of the PHD fingers of MLL5, TAF3, and
2K17, and 2RI7.
(C) Binding affinities of mutated PHF20 PHD for the indicated histone peptides a
(D and E) Overlays of 1H,15N HSQC spectra of the mutated PHF20 PHD fingers c
(F) Residues of the PHF20 PHD finger, found mutated in cancer, are shown as s
(G) Binding affinities of the cancer-relevant mutants of the PHF20 PHD finger fo
by NMR.
(H) Overlays of 1H,15N HSQC spectra of the cancer-relevant mutants of the PHF
NB, no binding.
1164 Cell Reports 17, 1158–1170, October 18, 2016(Figure 6B). Lack of any CSPs in the spectrum demonstrated that
the PHF20 PHD finger does not recognize methylated p53.
Despite some similarities in the amino acid (aa) sequences of
dimethylated H3K4 and p53 (Tudor2 associates with
p53K370me2 and p53K382me2 almost equally well; Cui et al.,
2012), superimposition of the H3K4me2 peptide with the
p53K370me2 peptide bound to Tudor2 provides a possible
explanation for the inability of Tudor2 to recognize H3K4me2
(Figure 6D). Most likely, the positively charged N terminus of
H3A1 and the side chain of H3R2 would be repelled from the
positively charged surface of Tudor2, where p53S367 and
p53H368 are bound, and the neutral H3Q5-T6 sequence lacks
the capacity to electrostatically interact with the negatively
charged surface of Tudor2, where p53K372 and p53K373 are
bound. In contrast, the absence of the AR sequence N-terminal
to dimethyllysine likely precludes binding of the PHF20 PHD
finger to dimethylated p53. Together, these results demonstrate
that, although both reader domains in PHF20 exhibit preference
for dimethyllysine species, their functions do not overlap.
Conclusions
Both histone marks, H4K16ac and H3K4me, are vital epigenetic
PTMs linked to transcriptional regulation. Accumulating evi-
dence suggests that these modifications and the enzymatic
complexes that produce them, such as MOF-NSL and MLL1,
function in a highly cooperative manner (Dou et al., 2005; Zhao
et al., 2013b). Although themechanism underlying this close cor-
relation is poorly understood, it has been suggested that WDR5,
a component of both MOF-NSL and MLL1 complexes, plays a
role (Dou et al., 2005; Li and Dou, 2010). Structural analysis of
the WD40 domain of WDR5, however, reveals that this protein
associates with the H3 N terminus regardless of the methylation
state of H3K4 (Couture et al., 2006; Ruthenburg et al., 2006;
Schuetz et al., 2006), leaving the question of its possible role in
functional cooperation of the enzymatic activities of the two
complexes open. In this study, we identified a relationship be-
tween the H4K16ac- and H3K4me-generating complexes. We
show that the PHD finger of PHF20, a core subunit of the
MOF-NSL HAT complex responsible for writing H4K16ac, rec-
ognizes H3K4me2, a mark generated by the MLL1 methyltrans-
ferase complex (Milne et al., 2002) (Figure 6E). Binding of the
PHD finger to H3K4me2 is required for PHF20-dependent
histone acetylation, occupancy of PHF20 at target genes, and
transcriptional activation of these genes. Our results indicate
that PHF20 links MOF to H3K4me2-mediated cellular processes
and suggest amodel for rapid propagation of H4K16ac-enrichedonserved residues are colored light blue, orange, and yellow, respectively. The
ding site residues of PHF20 and the Y17E mutant of BPTF, are circled.
the Y17E mutant of BPTF. The histone peptide is yellow. PDB codes are 4L58,
s measured by tryptophan fluorescence.
ollected upon titration with the indicated peptides.
ticks in red and labeled.
r H3K4me2 relative to the binding affinity of the WT PHD finger as measured
20 PHD finger collected upon titration with the H3K4me2 peptide.
Figure 5. H3K4me2-Binding Activity of PHD Is Essential for PHF20 to Regulate Gene Expression and Cancer Cell Growth and Survival
(A) qRT-PCR analysis of gene expression in control (shNT) and PHF20 KD (shPHF20) cells.
(B) qRT-PCR analysis of H4K16acChIP on gene promoters in control (shNT) and PHF20 KD (shPHF20) cells. (A andB) Error bars represent SEMof three biological
replicates.
(legend continued on next page)
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Figure 6. Functional Coupling between
Tudor2 and PHD of PHF20
(A and B) Superimposed 1H,15N HSQC spectra of
the Tudor2 and PHD domains of PHF20 collected
upon titration with the indicated peptides. Spectra
are color coded according to the protein:peptide
molar ratio (inset).
(C) Binding affinities of PHD and Tudor2 and
alignment of the p53 and H3 sequences. Basic
residues are in blue.
(D) The electrostatic surface potential of the PHF20
Tudor2 domain bound to the p53K370me2 peptide
is shown (PDB 2LDM). Blue and red colors repre-
sent positive and negative charges, respectively.
The p53K370me2 peptide (magenta) is manually
superimposed with the histone H3K4me2 peptide
(green) derived from the PHF20 PHD-H3K4me2
complex.
(E) A model depicting a potential role of PHF20
readers in linking H3K4 methylation with H4K16
acetylation as well as p53 methylation and
acetylation.open chromatin. Because the MOF complex contains several
subunits capable of binding to histones or DNA, including
H3-recognizing WDR5 and putative DNA-binding domains
in the NSL2 subunit, we expect that multiple contacts
contribute and/or fine-tune the MOF recruitment to specific
chromatin loci. Further studies are needed to investigate the
interplay of the histone- and DNA-binding activities within the
MOF complex.
Besides being a subunit of NSL, MOF is present in another
evolutionarily conserved HAT complex, MSL (Li and Dou, 2010;
Li et al., 2009; Zhao et al., 2013b). Although both NSL and(C) Western blot analysis of PHF20 and H4K16ac levels in control (shNT), PHF20 KD (shPHF20), and KD cells rescued with theWT PHF20 or E662Kmutant. To
H4 and actin were used as loading controls. The density of H4K16ac bands was quantified using ImageJ.
(D) qRT-PCR analysis of H4K16ac ChIP on promoters of CCNA1 and HMGB2 genes in cells as in (C).
(E) qRT-PCR analysis of CCNA1 and HMGB2 gene expression in cells as in (C).
(F) Cell proliferation assays of cells as in (C).
(G and H) Colony formation assays of cells as in (C). Representative crystal-violet-stained cells are shown in (G), and quantification of six replicates is shown in (
**p < 0.01. See also Figure S3 and Tables S4 and S5.
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04,MSL complexes efficiently acetylate
H4K16, only NSL is able to acetylate
non-histone proteins, including p53 (Li
et al., 2009; Rea et al., 2007). Because
the NSL-MOF complex, but not the
MSL-MOF complex, contains the PHF20
subunit (Zhao et al., 2013b) whose
Tudor2 binds to dimethylated p53 (Cui
et al., 2012), it is tempting to suggest
that PHF20might have a role in promoting
p53 acetylation by MOF (Figure 6E).
Another possibility is that the distinctly
different dimethyllysine-binding activities
of Tudor2 and PHD in PHF20 tether or
stabilize p53 at the genomic sites en-
riched in H3K4me2. It will be interesting
in future studies to explore whether thfunctional coupling involving the two PHF20 readers exists.
is also essential to establish the role of PHF20 in regulati
MOF activity on p53 as well as in p53-mediated DNA dama
response, cell cycle regulation, and apoptosis.
EXPERIMENTAL PROCEDURES
Materials
shRNA constructs were purchased from Sigma. The PHF20-targeting shR
sequences were 50-CCCGAGAAATACACCTGTTAT-30 and 50-ATTGTG
CACTGATGATAAAC-30. The following antibodies were purchased: an
PHF20 (3934S, 1:1,000) antibody from Cell Signaling, anti-FLAG (F-18tal
H).
1:5,000) and anti-tubulin (T8328, 1:5,000) antibodies from Sigma, anti-
H4K16ac (07-329, 1:1,000) antibody from Millipore, and anti-total H3
(ab1791, 1:5,000) antibody from Abcam.
Cloning and Protein Purification
The PHF20 PHD domain construct (aa 651–699) was cloned from cDNA of
PHF20 (Open Biosystems) into a pGEX-6P-1 (GE Healthcare) expression
vector with ampicillin resistance. The WT and mutant proteins were expressed
in E. coli Rosetta-2(DE3)pLysS cells grown in either Luria broth or 15NH4Cl
minimal media, supplemented with 150 mM ZnCl2. After induction with isopro-
pyl-ß-D-1-thiogalactopyranoside (IPTG; 0.5 mM) for 16–18 hr at 18C, cells
were harvested by centrifugation at 5,000 rpm and lysed by sonication. GST
fusion proteins were purified on glutathione Sepharose 4B beads (Pierce,
Fisher). The GST tag was cleaved with PreScission protease (Amersham).
When necessary, the proteins were further purified by size-exclusion chroma-
tography over a HiPrep 16/60 Sephacryl S-100 column (GE Healthcare) and
concentrated in Millipore concentrators (Millipore). Tudor2 (aa 58–148) was
purified as described previously (Zhang et al., 2016).
For NMR structure determination of the PHD finger in complex with an
H3K4me2 peptide, a DNA fragment encoding PHF20 residues 646–699 was
inserted in a pTEV vector encoding a tobacco etch virus (TEV) protease-
cleavable N-terminal hexahistidine tag. The protein was overexpressed in
E. coli Rosetta (DE3) pLysS cells cultured in 15N- and 15N/13C-enriched M9
media supplemented with 100 mM ZnSO4. Cells were grown at 37
C to an
OD600 (optical density measured at a wavelength of 600 nm) of about 0.6,
transferred to 15C, induced with IPTG (0.5 mM) after 45 min, and cultured
for another 16–20 hr before harvesting by centrifugation. Cell pellets were
resuspended in 50 mM sodium phosphate (pH 7.5), 300 mM NaCl with
5 mM imidazole, and 5 mM PMSF and then lysed using an Emulsiflex C-5
high-pressure homogenizer. Cell debris was removed by centrifugation. The
protein was purified by metal chelation chromatography using Ni2+-NTA
resin and further purified by size-exclusion chromatography using a Superdex
75 column after cleavage of the hexahistidine tag with TEV protease
overnight at 4C. Protein concentration was determined by UV absorption at
280 nm with the absorption coefficient predicted by ProtParam (http://www.
expasy.org/).
PCR Mutagenesis
Point mutants of the PHF20 PHD finger were generated using the Stratagene
QuikChange XL Site Directed Mutagenesis Kit and Pfu turbo DNA polymerase
(Stratagene). All constructs were confirmed by DNA sequencing.
Peptide Microarray and Peptide Pull-Down Assay
Peptide microarray and peptide pull-down assays were performed as
described previously (Wen et al., 2014). In brief, biotinylated histone peptides
were printed in triplicate onto a streptavidin-coated slide (PolyAn) using a
VersArray Compact Microarrayer (Bio-Rad). After a short blocking with biotin
(Sigma), the slides were incubated with the GST-PHF20 PHD in binding buffer
(50 mM Tris-HCl [pH 7.5], 250 mM NaCl, 0.1% Nonidet P-40 [NP-40], 1 mM
PMSF, 20% fetal bovine serum) overnight at 4C with gentle agitation. After
being washed with the same buffer, the slides were probed with an anti-GST
primary antibody and then a fluorescein-conjugated secondary antibody and
visualized using a GenePix 4000 scanner (Molecular Devices). For the peptide
pull-down assays, 1 mg biotinylated histone peptides with different modifica-
tions was incubated with 1 mg GST-PHF20 PHD in binding buffer (50 mM
Tris-HCl [pH 7.5], 250 mM NaCl, 0.1% NP-40, 1 mM PMSF) overnight.
Streptavidin beads (Amersham) were added to the mixture, and the mixture
was incubated for 1 hr with rotation. The beads were then washed three times
and analyzed using SDS-PAGE and western blotting.
X-Ray Crystallography
PHF20 PHD C674S (aa 651–699) was concentrated to 16 mg/ml in 20 mM
Tris-HCl (pH 7.5), supplemented with 130 mM NaCl and 5 mM dithiothreitol.
The protein solution was incubated overnight with the H3K4me2 peptide
(aa 1–12) in a 1:1.5molar ratio before crystallization. Crystals were grown using
the sitting-drop diffusion method at 4C by mixing 600 nL protein-peptide
solution with 600 nL well solution composed of 0.1 M bis-tris propanol(pH 6.5), 2.55 M ammonium sulfate titrated with 6 mL/1 mL 1 N HCl. Although
the histone peptide was present, PHF20 PHD C674S was crystallized in an
apo-state. Cryoprotected crystals (soaked in mother liquor with 30%
glycerol) were picked and plunged into liquid nitrogen. X-ray diffraction data
were collected from a single crystal at National Synchrotron Light Source
X25 (BNL) beamline. The protein structure was solved using Single-wave-
length Anomalous Dispersion method with Zn anomalous signal. Datasets
were processed with HKL2000 and CCP4. Refinement was carried out using
Phenix (Adams et al., 2010), and the model was built with Coot (Emsley and
Cowtan, 2004). Data and refinement statistics are summarized in Table S2.
NMR Titration Experiments
The 1H,15N HSQC spectra of 0.1 mM uniformly 15N-labeled WT or mutant PHD
domain of PHF20 in PBS (pH 6.7), 5 mM dithiothreitol buffer or Tudor2 in
25 mM Tris-HCl (pH 7.5), 150 mM NaCl, 5 mM dithiothreitol buffer were
collected at 298K on Varian INOVA 600- and 500-MHz spectrometers as
described previously (Klein et al., 2014). The binding was characterized by
monitoring chemical shift changes as 12-mer histone tail peptides (synthe-
sized by the University of Colorado Denver Peptide Core Facility) or p53
(aa 377–387) was added stepwise. The KDs were determined using a nonlinear
least-squares analysis in KaleidaGraph and the equation
Dd=Ddmax

ð½L+ ½P+KdÞ 
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
ð½L+ ½P+KdÞ2  4½P½L
q 
2½P;
where [L] is concentration of the peptide, [P] is concentration of the protein, Dd
is the observed chemical shift change, and Ddmax is the normalized chemical
shift change at saturation. Normalized chemical shift changes were calculated
using the equationDd =
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
ðDdHÞ2 + ðDdN=5Þ2
q
, whereDd is the change in chem-
ical shift in parts per million (ppm).
NMR Structure Determination
NMR experiments were recorded at 25C using a 700-MHz Bruker Avance III
spectrometer equipped with a cryoprobe. The NMR data were processed and
analyzed using NMRPipe (Delaglio et al., 1995) and NMRViewJ (Johnson and
Blevins, 1994). Protein samples were in 25 mM sodium phosphate buffer (pH
7.0), 1.5 mM NaN3, 0.3 mM sodium 4,4-dimethyl-4-silapentane-1-sulphonate,
10% D2O, and 90% H2O. The 11-residue C-terminally amidated H3K4me2
peptide [ART(Kme2)QTARKST] was purchased from GenScript and purified
by reverse-phase high-performance liquid chromatography (HPLC) using a
Jupiter 5u C18 300A preparative column (Phenomenex). For structure determi-
nation, PHF20 PHD and H3K4me2 peptide were at concentrations of 1.5
and 6 mM, respectively. A series of standard NMR experiments was recorded
for backbone and side-chain resonance assignments including 2D correlation
spectroscopy (COSY), 1H,15N and 1H,13CHSQC, and 3DHNCACB, CBCA(CO)
NH, HNCO, HN(CA)CO, HBHA(CO)NH, CCH-TOCSY, 15N NOESY-HSQC, and
13C NOESY-HSQC. 15N NOESY-HSQC and 13C NOESY-HSQC optimized for
aliphatic and aromatic spectral regions were recorded with a mixing time of
120 ms to generate distance restraints. 3D 13C,15N-filtered, 13C/15N-edited
NOESY experiments (Zwahlen et al., 1997) were recorded with a 120-ms mix-
ing time to unambiguously identify intermolecular nuclear Overhauser
enhancement (NOEs) (Figure S2).
For structure calculations, interproton distances were derived from
15N NOESY-HSQC, 13C NOESY-HSQC, and 13C,15N-filtered, 13C/15N-edited
NOESY experiments and categorized into five distance ranges with upper
limits of 2.8, 3.5, 4.5, 5.5, and 7.5 A˚; the 7.5 A˚ is to account for possible spin
diffusion in very weak NOE signals. Hydrogen bonds were determined from
deuterium exchange experiments and given upper limits of 3.2 A˚ (for N-O)
and 2.2 A˚ (for HN-O). For all distance restraints, a lower limit of 1.8 A˚ was
used. Dihedral angles 4 and c were derived from TALOS (Cornilescu et al.,
1999) and CSI (Wishart and Sykes, 1994) analysis. Two hundred structures
of free PHF20 were initially calculated using the simulated annealing protocol
of CYANA (G€untert, 2004). Twenty of these structures with the lowest energies
were then used to analyze for violations and obtain additional SANE-assisted
NOE assignments for PHF20 (Duggan et al., 2001). Several iterations of
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below 0.3 A˚ and 5, respectively. Next, the above procedure was repeated but
introducing the H3K4me2 peptide in the calculations. Two hundred structures
of the PHF20-H3K4me2 complex were calculated, and 100 of those with the
lowest energies were refined using AMBER (Case et al., 2005). In AMBER
refinement, the structures were subjected to 30 ps 30,000 steps of simulated
annealing using a generalized Born solvent model (Botuyan et al., 2001; Tsui
and Case, 2000-2001). The system was first heated to 1,000 K in the first
8 ps and remained at 1,000 K for 2 ps. It was then annealed and cooled to
0 K for the next 20 ps. Force constants were set as follows: 20 kcal mol1 A˚2
for NOE-derived distance restraints, 40 kcal mol1 A˚2 for hydrogen bond re-
straints, 70 kcal mol1 rad2 for dihedral angle restraints, 100 kcal mol1rad2
for chirality restraints, and 150 kcal mol1rad2 for omega angle restraints. At
the end of the refinement, 20 structures with the lowest AMBER energies and
violations were selected for final structure statistics (Table S3).
Fluorescence Spectroscopy
Spectra were recorded at room temperature on a Fluoromax-3 spectrofluo-
rometer (HORIBA). The samples containing the PHF20 PHD domain in PBS
(pH 6.8), 10 mM DTT buffer, and progressively increasing concentrations of
histone peptide were excited at 280 nm. Emission spectra were recorded
over a range of wavelengths between 310 and 405 nm with a 0.5-nm step
size and a 1-s integration time and averaged over three scans. The KD
values were determined using a nonlinear least-squares analysis and the
equation
DI=DImax

ð½L+ ½P+KdÞ 
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
ð½L+ ½P+KdÞ2  4½P½L
q 
2½P;
where [L] is the concentration of the histone peptide, [P] is the concentration of
the protein, DI is the observed change of signal intensity, and DImax is the dif-
ference in signal intensity of the free and bound states of the protein. The KD
value was averaged over three separate experiments, with error calculated
as the SD between the runs.
Cell Culture and RNA Interference
H1792 and all lung cancer cell lines were cultured in RPMI 1640 (Cellgro) sup-
plemented with 10% fetal bovine serum (Sigma). For shRNA knockdown (KD),
293T cells were cultured in DMEM (Cellgro) and co-transfected with pMD2.G
and pPAX2 (Addgene) together with pLKO-shRNA constructs or a non-target-
ing pLKO-shRNA (shNT). Viral supernatants were harvested after 48 hr. For in-
fections, H1792 cells were incubated with viral supernatants in the presence of
8 mg/ml polybrene. After 48 hr, puromycin (2 mg/ml) was added to the medium.
Cells were grown, with selection for 5–7 days to select for stable KD cells.
Colony Formation Assays
H1792 cells treatedwith shRNAswere seeded in six-well plates (800 cells/well)
and grown in RPMI 1640 plus 10% FBS at 37C for 14 days. Cells were fixed,
stained with 0.005% crystal violet blue, and photographed. Colony numbers
were counted using ImageJ software with size cutoff of 75 mm. Results were
quantitated from at least three independent replicates.
ChIP
ChIP analysis was performed essentially as described previously (Wen et al.,
2014). In brief, cells were crosslinked with 1% formaldehyde for 10 min at
room temperature, and the reaction was stopped with 125 mM glycine. Nuclei
were isolated by resuspending the cells in swelling buffer containing 5 mM
piperazine-N,N’-bis(ethanesulfonic acid) (PIPES; pH 8.0), 85 mM KCl, 1%
NP-40, and complete protease inhibitors for 20 min at 4C. The isolated nuclei
were resuspended in nuclei lysis buffer (50 mM Tris [pH 8.0], 10 mMEDTA, 1%
SDS) and sonicated using a Bioruptor Sonicator (Diagenode). Samples were
immunoprecipitated with 2–4 mg of the appropriate antibodies overnight at
4C. Immunoprecipitates were washed twice with dialysis buffer (50 mM Tris
[pH 8.0], 2 mM EDTA, 0.2% Sarkosyl) and four times with IP wash buffer
(100 mM Tris [pH 8.0], 500 mM LiCl, 1% NP-40, and 1% deoxycholic acid so-
dium salt). After reverse crosslinking was performed, the DNA was eluted and
purified using a PCRpurification kit (QIAGENe). The primer sequences used for
ChIP analyses are listed in Table S4.1168 Cell Reports 17, 1158–1170, October 18, 2016RT-PCR, Real-Time PCR, and RNA-Seq Analysis
RT-PCR and real-time PCR were performed as described previously (Wen
et al., 2014). mRNA was prepared using the RNeasy Plus kit (QIAGEN) and
reverse-transcribed using the First Strand Synthesis Kit (Invitrogen). Quanti-
tative real-time RT-PCR was performed on an ABI 7500-FAST Sequence
Detection System using the Power SYBR Green PCR Master Mix (Applied
Biosystems). Gene expression was calculated after normalization to GAPDH
levels using the comparative Ct (cycle threshold) method. The primer se-
quences used for RT-PCR are listed in Table S5. Experimental data are pre-
sented as means ± SD unless stated otherwise. Statistical significance was
calculated by two-tailed unpaired t test on two experimental conditions
with p < 0.05 considered statistically significant.
RNA-seq samples were sequenced using the Illumina Hiseq 2000. Three
biological replicates were prepared for each condition. The sequencing reads
were mapped to human genome (hg19) by TopHat (version 2.0.10) (Kim et al.,
2013). The overall mapping rate is 95%–99%. The number of fragments in
each known gene from RefSeq database (Pruitt et al., 2012) (downloaded
from UCSC Genome Browser on June 2, 2014) was enumerated using
htseq-count from HTSeq package (version 0.6.0) (http://www-huber.embl.
de/users/anders/HTSeq/). The differential expression between conditions
was statistically assessed by R/Bioconductor package DESeq (Anders and
Huber, 2010) (version 1.18.0). Genes with false discovery rate % 0.05 and
fold changeR 2were called significant. Hierarchical clustering was performed
by hclust function in R using their expression values estimated by DESeq. The
expression values of each gene across samples were centered by median and
scaled by SD before clustering. Euclidean distance and ward.D2 clustering
method were used. The heatmap was plotted by heatmap.2 function in R.
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